Evidence map›Paper›PMID 28025640›Full record

ReviewBioMed research international2016

The Potential Role of Graphene in Developing the Next Generation of Endomaterials.

Nikolaos Patelis, Demetrios Moris, Sean Matheiken, Chris Klonaris

Abstract readReview
In one paragraph

Review in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Coatings for Cardiovascular Stents-An Up-to-Date Review.International journal of molecular sciences · 2024
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nikolaos PatelisFirst Department of Surgery, Vascular Unit, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece.ORCID 0000-0003-2328-2162
Demetrios MorisLerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.ORCID 0000-0002-5276-0699
Sean MatheikenVascular Unit, Royal Free Hospital, London, UK.
Chris KlonarisFirst Department of Surgery, Vascular Unit, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Graphene is the first 2-dimensional material and possesses a plethora of original properties. Graphene and its derivatives have exhibited a great potential in a number of fields, both medical and nonmedical. The aim of this review is to set the theoretical basis for further research in developing graphene-based endovascular materials. An extensive search was performed in medical and bioengineering literature. Published data on other carbon materials, as well as limited data from medical use of graphene, are promising. Graphene is a promising future material for developing novel endovascular materials. Certain issues as biocompatibility, biotoxicity, and biostability should be explored further.

Indexed as

Biocompatible MaterialsBlood Vessel ProsthesisGraphiteAnimalsHumansBiocompatible MaterialsGraphite

Identifiers

PMID28025640
PMCPMC5153502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.